These studies show that modulating the PI3K/Akt signaling pathway, regulating the TNF-α-mediated death receptor pathway, and inhibiting apoptosis through the Bcl-2 family and CytC-mediated mitochondrial pathway are key to the preventive and therapeutic effects of certain probiotics in colitis. Here, AKT1 is linked to colitis.